Showing 3401-3410 of 5910 results for "".
- Study Identifies Mechanism that May Cause Blindnesshttps://modernod.com/news/study-identifies-mechanism-that-may-cause-blindness/2479090/Using laboratory-grown roundworms as well as human and mouse eye tissue, University of Maryland School of Medicine (UMSOM) researchers have identified a new potential mechanism for age-related macular degeneration—the leading cause of blindness among older adults. The UMSOM researchers say
- ProQR Announces Publication in Nature Medicine for Sepofarsen in Leber Congenital Amaurosis 10https://modernod.com/news/proqr-announces-publication-in-nature-medicine-for-sepofarsen-in-leber-congenital-amaurosis-10/2479077/ProQR Therapeutics announced the publication in the scientific journal
- Study: Glaucoma May Be More than Just an Issue of Eye Pressurehttps://modernod.com/news/study-glaucoma-may-be-more-than-just-an-issue-of-eye-pressure/2479078/A chemical known to protect nerve cells also slows glaucoma, the leading cause of irreversible blindness, results of a new study in rats show. Led by researchers at NYU Grossman School of Medicine, the study centers on the watery fluid inside the eye on which its function depends. Fluid pr
- LION Eye Group to Develop New Retail Stores in New Yorkhttps://modernod.com/news/lion-eye-group-to-develop-new-retail-stores-in-new-york/2479074/New York-based LION Eye Group announced its intent to move forward with “LION Express,” a state-of-the art, eyewear focused, retail optometric store. The group is currently scouting locations in Garden City, Huntington,
- Neurophth Announces IND Approval in China for Leber Hereditary Optic Neuropathy Gene Therapyhttps://modernod.com/news/neurophth-announces-ind-approval-in-china-for-leber-hereditary-optic-neuropathy-gene-therapy/2479055/Neurophth Biotechnology announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has approved the company’s investigational new drug (IND) application of NR082 (recombinant adeno-associated virus serotype 2 carrying ND4 gene; rAAV2-ND
- New Educational Resource On Importance of Eye Protection in Sports/Recreational Activititeshttps://modernod.com/news/new-educational-resource-on-importance-of-eye-protection-in-sports-recreational-activitites/2479046/The International Sports Vision Association (ISVA) and Zyloware Eyewear announced the launch of Protect. Prevent. Play., a new educational resource designed to help eye care professionals educate parents, coaches, teachers, athletic trainers and athletes of all ages and skill levels abou
- Study: Drinking Wine May Help Protect Against Cataractshttps://modernod.com/news/study-drinking-wine-may-help-protect-against-cataracts/2479033/People who consume alcohol moderately appear less likely to develop cataracts that require surgery. Wine consumption showed the strongest protective effect, suggesting that antioxidants which are abundant in red wine may play a role in cataract prevention. However, people who d
- Nursing Homes See 96 Percent Decline In COVID Cases Since Vaccine Rollouthttps://modernod.com/news/nursing-homes-see-96-percent-decline-in-covid-cases-since-vaccine-rollout/2479027/The American Health Care Association and National Center for Assisted Living (AHCA/NCAL), which represents more than 14,000 nursing homes and long term care facilities across the US, released a
- Refractive Surgery Council Reports Demand for Laser Vision Correction Procedures Increases During COVID-19 Pandemichttps://modernod.com/news/refractive-surgery-council-reports-demand-for-laser-vision-correction-procedures-increases-during-covid-19-pandemic/2479020/The COVID-19 pandemic has caused many people to reassess their lifestyles and health, including eye health, resulting in an increased interest in laser vision correction procedures such as LASIK and SMILE, according to the Refractive Surgery Council (RSC). RSC reports an uptick in procedur
- EssilorLuxottica Signs Agreement to Acquire Walmanin the UShttps://modernod.com/news/essilorluxottica-signs-agreement-to-acquire-walmanin-the-us/2479016/EssilorLuxottica has entered into an agreement to acquire US-based lab network Walman. Terms of the deal were not disclosed. EssilorLuxottica’s investment in Walman will allow customers to leverage existing and future opportunities to